[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK333388A - Farmaceutiske praeparater indeholdende mikroniserede ebselen-krystaller - Google Patents

Farmaceutiske praeparater indeholdende mikroniserede ebselen-krystaller

Info

Publication number
DK333388A
DK333388A DK333388A DK333388A DK333388A DK 333388 A DK333388 A DK 333388A DK 333388 A DK333388 A DK 333388A DK 333388 A DK333388 A DK 333388A DK 333388 A DK333388 A DK 333388A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations containing
containing micronized
crystals
ebselen
Prior art date
Application number
DK333388A
Other languages
English (en)
Other versions
DK173628B1 (da
DK333388D0 (da
Inventor
Axel Roemer
Juergen Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DK333388D0 publication Critical patent/DK333388D0/da
Publication of DK333388A publication Critical patent/DK333388A/da
Application granted granted Critical
Publication of DK173628B1 publication Critical patent/DK173628B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK198803333A 1987-06-20 1988-06-17 Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller DK173628B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen
DE3720493 1987-06-20

Publications (3)

Publication Number Publication Date
DK333388D0 DK333388D0 (da) 1988-06-17
DK333388A true DK333388A (da) 1988-12-21
DK173628B1 DK173628B1 (da) 2001-05-07

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803333A DK173628B1 (da) 1987-06-20 1988-06-17 Farmaceutiske præparater indeholdende mikroniserede EBSELEN-krystaller

Country Status (25)

Country Link
US (1) US5021242A (da)
EP (1) EP0296389B1 (da)
JP (1) JPH0713016B2 (da)
KR (1) KR970005322B1 (da)
AT (1) ATE69165T1 (da)
AU (1) AU603454B2 (da)
CA (1) CA1310906C (da)
DD (1) DD271056A5 (da)
DE (2) DE3720493A1 (da)
DK (1) DK173628B1 (da)
ES (1) ES2041736T3 (da)
FI (1) FI88256C (da)
GE (1) GEP19960342B (da)
GR (1) GR3003084T3 (da)
HU (1) HU200096B (da)
IE (1) IE63512B1 (da)
LT (1) LT3669B (da)
LV (1) LV10381B (da)
MX (1) MX169170B (da)
NO (1) NO175133C (da)
NZ (1) NZ225066A (da)
PT (1) PT87767B (da)
RU (1) RU1834657C (da)
UA (1) UA12648A (da)
ZA (1) ZA884025B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
DE69328128T2 (de) * 1993-10-27 2000-08-24 Daiichi Pharmaceutical Co., Ltd. Granuläre zubereitung
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
ES2181868T3 (es) * 1995-02-28 2003-03-01 Aventis Pharma Inc Composicion farmaceutica para compuestos de piperidinoalcanol.
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080293777A1 (en) * 2007-05-23 2008-11-27 Erlanson Daniel A Weight Loss Treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
ZA884025B (en) 1988-12-20
GR3003084T3 (en) 1993-02-17
HUT50037A (en) 1989-12-28
US5021242A (en) 1991-06-04
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
DD271056A5 (de) 1989-08-23
NO882615D0 (no) 1988-06-14
FI882912A0 (fi) 1988-06-17
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
DK173628B1 (da) 2001-05-07
LT3669B (en) 1996-01-25
KR890000084A (ko) 1989-03-11
NO175133B (no) 1994-05-30
AU603454B2 (en) 1990-11-15
MX169170B (es) 1993-06-23
JPH01100125A (ja) 1989-04-18
ATE69165T1 (de) 1991-11-15
FI88256C (fi) 1993-04-26
KR970005322B1 (ko) 1997-04-15
IE881628L (en) 1988-12-20
PT87767B (pt) 1992-10-30
ES2041736T3 (es) 1996-07-16
DE3866033D1 (de) 1991-12-12
NO175133C (no) 1994-09-07
DK333388D0 (da) 1988-06-17
NO882615L (no) 1988-12-21
LTIP903A (en) 1995-03-27
GEP19960342B (en) 1996-02-20
CA1310906C (en) 1992-12-01
FI882912A (fi) 1988-12-21
IE63512B1 (en) 1995-05-03
NZ225066A (en) 1990-07-26
FI88256B (fi) 1993-01-15
LV10381A (lv) 1995-02-20
UA12648A (uk) 1997-02-28
PT87767A (pt) 1989-05-31
RU1834657C (ru) 1993-08-15
AU1811688A (en) 1988-12-22
JPH0713016B2 (ja) 1995-02-15
LV10381B (en) 1995-06-20

Similar Documents

Publication Publication Date Title
DK333388A (da) Farmaceutiske praeparater indeholdende mikroniserede ebselen-krystaller
DE3686483D1 (de) Arzneimittel.
SE8300736D0 (sv) Novel pharmacologically active compounds
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
JPS5548356A (en) Drug added animal feedstuff based on liver powder
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
SE8404065D0 (sv) Novel biologically active compounds
ES2012339B3 (es) Preparacion oral de ajo y procedimiento para su fabricacion
SE8600658D0 (sv) Novel composition of matter
DK243280A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
AU530678B2 (en) Phosphono-hydroxy-acetic acid
GB2021409A (en) Pharmaceutical composition
ATE7698T1 (de) Vincamin-saccharinat und dieses enthaltende arzneimittel.
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired